Seema Qayum
Critical Care Medicine · Gretna, LANPI 1679992549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 27.8% of the total. 2025 is the largest year on record at $571, 3.2 times the $179 reported in 2023. That places this record below the midpoint for critical care medicine clinicians in LA, where the typical reported total is $950.
Across 10 payments — averaging $88.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$245
- Abbott$148
- Inspire Medical Systems, Inc.$128
- Boehringer Ingelheim$98
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$96
- Sanofi$85
- plus $80 from 2 others
What the payments were for
- Food & beverage$880100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $245 |
| Abbott | 1 | $148 |
| Inspire Medical Systems, Inc. | 1 | $128 |
| Boehringer Ingelheim | 1 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $96 |
| Sanofi | 1 | $85 |
| Astellas Pharma US Inc | 2 | $65 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$148
- Inspire$128
- FASENRA$125
- TEZSPIRE$120
How this compares
$880 in reported general payments places this provider in the 45th percentile of 72 critical care medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone | 15 | $13,629 |
| Valganciclovir Hcl | 13 | $2,475 |
| Sirolimus | 11 | $1,788 |
| Mirtazapine | 17 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $315 |
| Azithromycin | 16 | $177 |
| Famotidine | 19 | $164 |
| Losartan Potassium | 11 | $150 |
| Amlodipine Besylate | 24 | $107 |
| Gabapentin | 18 | $88 |
| Prednisone | 20 | $85 |
| Furosemide | 13 | $15 |
| Trazodone Hcl | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Gretna
- Abdulla Majid-MoosaBaton Rouge$202K
- Gerardo San PedroBossier City$76K
- Richard MorrisonShreveport$24K
- Laurie GrierShreveport$23K
- Fidencio DavalosLake Charles$20K
- Jonathan EatonShreveport$19K
- Steven ConradShreveport$15K
- Ahmad SharayahBaton Rouge$12K
- Ronald FieldsBaton Rouge$11K
- Jonathan VignesLafayette$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.